Ischemic but not thermal pain sensitivity varies across the menstrual cycle

Psychosomatic Medicine

Volumn 59, Issue 5, 1997, Pages 512-520

  Fillingim, Roger B ^a,c   Maixner, William ^a   Girdler, Susan S ^b   Light, Kathleen C ^b   Harris, M Brennan ^a   Sheps, David S ^b   Mason, George A ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Gonadal hormones; Ischemic pain; Menstrual cycle; Opioids; Thermal pain

Indexed keywords

BETA ENDORPHIN; ESTROGEN; LUTEINIZING HORMONE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; EMOTION; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; ISCHEMIA; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; NOCICEPTION; NORMAL HUMAN; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; THERMAL EXPOSURE;

EID: 0030766031     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199709000-00008     Document Type: Article

References (54)

1. Drury RA, Gold RM: Differential effects of ovarian hormones on reactivity to foot-shock in rats. Physiol Behav 20:187-191, 1977
2. Frye CA, Bock BC, Kanarek RB: Hormonal milieu affects tailflick latency in female rats and may be attenuated by access to sucrose. Physiol Behav 52:699-706, 1992
3. Leer MN, Bradbury A, Maloney JC, et al: Elevated shock threshold in sexually receptive female rats. Physiol Behav 42:617-620, 1988
4. Frye CA, Cuevas CA, Kanarek RB: Diet and estrous cycle influence pain sensitivity in rats. Pharmacol Biochem Behav 45:255-260, 1993
5. Ryan SM, Maier SF: The estrous cycle and estrogen modulate stress-induced analgesia. Behav Neurosci 102:371-380, 1988
6. Ratka A, Simpkins JW: A modulatory role for luteinizing hormone-releasing hormone in nociceptive responses of female rats. Endocrinology 127:667-673, 1990
7. Berglund LA, Simpkins JW: Alterations in brain opiate receptor mechanisms on proestrous afternoon. Neuroendocrinology 48:394-400, 1988
8. Berglund LA, Derendorf H, Simpkins JW: Desensitization of brain opiate receptor mechanisms by gonadal steroid treatments that stimulate luteinizing hormone secretion. Endocrinology 122:2718-2726, 1988
9. Dawson Basoa MB, Gintzler AR: 17-Beta-estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res 601:241-245, 1993
10. Boyle CA, Berkowitz GS, Kelsey JL: Epidemiology of premenstrual symptoms. Am J Pub Health 77:349-350, 1987
11. Huerta-Franco MR, Malacara JM: Association of physical and emotional symptoms with the menstrual cycle and life-style. J Reprod Med 38:448-454, 1993
12. Woods NF, Most A, Dery GK: Prevalence of perimenstrual symptoms. Am J Pub Health 72:1257, 1982
13. Kessel N, Coppen A: The prevalence of common menstrual symptoms. Lancet 2:61, 1963
14. Ylikorkala O, Dawood MY: New concepts in dysmenorrhea. Am J Obstet Gynecol 130:833-841, 1978
15. Facchinetti F, Martignoni E, Fioroni L, et al: Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. Cephalalgia 10:51-56, 1990
16. Silberstein SD, Merriam GR: Sex hormones and headache. J Pain Symptom Manage 8:98-114, 1993
17. Fillingim RB, Girdler SS, Booker DK, et al: Pain sensitivity in females with premenstrual dysphoric disorder: A preliminary report. J Women's Health 4:367-374, 1995
18. Herren RY: The effect of high and low female sex hormone concentration on the two-point threshold of pain and touch and upon tactile sensitivity. J Exp Psychol 16:324-327, 1933
19. Procacci P, Zoppi M, Maresca M, et al: Studies of the pain threshold in man. Bonica JJ (ed), Advances in Neurology. Vol 4. New York, Raven Press, 1974, 107-113
20. Hapidou EG, De Catanzaro D: Sensitivity to cold pressor pain in dysmenorrheic and non-dysmenorrheic women as a function of menstrual cycle phase. Pain 34:277-283, 1988
21. Goolkasian P: Cyclic changes in pain perception: An ROC analysis. Percept Psychophysiol 27:499-504, 1980
22. Goolkasian P: An ROC analysis of pain reactions in dysmenorrheic and nondysmenorrheic women. Percept Psychophysics 34:381-386, 1983
23. Rao SS, Ranganekar AG, Saifi AQ: Pain threshold in relation to sex hormones. Indian J Physiol Pharmacol 31:250-254, 1987
24. Tedford WH, Warren DEJ, Flynn WE: Alteration of shock aversion thresholds during the menstrual cycle. Percept Psychophysiol 21:193-196, 1977
25. Veith JL, Anderson J, Slade SA, et al: Plasma beta-endorphin, pain thresholds and anxiety levels across the human menstrual cycle. Physiol Behav 32:31-34, 1984
26. Girdler SS, Pedersen CA, Stern RA, Light KC: Menstrual cycle and premenstrual syndrome: Modifiers of cardiovascular reactivity in women. Health Psychol 12:180-192, 1993
27. Janal MN, Glusman M, Kuhl JP, et al: On the absence of correlation between responses to noxious heat, cold, electrical and ischemic stimulation. Pain 58:403-411, 1994
28. Lautenbacher S, Rollman GB, McCain GA: Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 59:45-53, 1994
29. Duncan GH, Feine JS, Bushnell MC, et al: Use of magnitude matching for measuring group differences in pain perception. In Dubner R, Gebhart GF, Bond MR (eds), Proceedings of the Vth World Congress on Pain. New York, Elsevier, 1989, 383-390
30. Reid RL: Premenstrual syndrome. In Leventhal JM, Hoffman JJ, Keith LG, et al (eds), Obstetrics, Gynecology, and Fertility. Chicago, Year Book Medical Publishers, 1985, 4-57
31. Girdler SS, Pedersen CA, Light KC: Thyroid axis function during the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology 20:395-403, 1995
32. Sternbach RA, Deems LM, Timmermans G, et al: On the sensitivity of the tourniquet pain test. Pain 3:105-110, 1977
33. Maixner W, Gracely RH, Zuniga JR, et al: Cardiovascular and sensory responses to forearm ischemia and dynamic hand exercise. Am J Physiol 259:R1156-1163, 1990
34. Gracely RH: Psychophysical assessment of human pain. Adv Pain Res Ther 3:805-824, 1979
35. Gracely RH, Dubner R, McGrath PA: Narcotic analgesia: fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations. Science 203:1261-1263, 1979
36. Spielberger CD, Gorusch RL, Lushene R, et al: Manual for the State-Trait Anxiety Inventory (Form Yl). Palo Alto, CA, Consulting Psychologists Press, 1983
37. Rosenstiel AK, Keefe FJ: The use of coping strategies in chronic low back pain patients: Relationship to patient characteristics and current adjustment. Pain 17:33-44, 1983
38. Keefe FJ, Caldwell DS, Queen KT, et al: Pain coping strategies in osteoarthritis patients. J Consult Clin Psychol 55:208-212, 1987
39. Parker JC, Smarr KL, Buescher KL, et al: Pain control and rational thinking: Implications for rheumatoid arthritis. Arthritis Rheum 32:984-990, 1989
40. Geisser ME, Robinson ME, Pickren WE: Differences in cognitive coping strategies among pain-sensitive and pain-tolerant individuals on the cold pressor test. Behav Ther 23:31-42, 1992
41. Lorr M, McNair DM: Profile of Mood States: Bipolar Form. San Diego, Educational and Industrial Testing Service, 1988
42. King AC, Taylor CB, Haskell WL: Effects of differing intensities and formats of 12 months of exercise training on psychological outcomes in older adults. Health Psychol 12:292-300, 1993
43. Krug R, Pietrowsky R, Fehm HL, et al: Selective influence of menstrual cycle on perception of stimuli with reproductive significance. Psychosom Med 56:410-417, 1994
44. Hamilton JA, Gallant S: Premenstrual symptom changes and plasma β-endorphin/β-lipotropin throughout the menstrual cycle. Psychoneuroendocrinology 13:505-514, 1988
45. Grevert P, Albert LH, Goldstein A: Partial antagonism of placebo analgesia by naloxone. Pain 16:129-143, 1983
46. Frid M, Singer G, Oei T, et al: Reactions to ischemic pain: interactions between individual, situational and naloxone effects. Psychopharmacology 73:116-119, 1981
47. Frid M, Singer G, Rana C: Interactions between personal expectations and naloxone: Effects on tolerance to ischemic pain. Psychopharmacology 65:225-231, 1979
48. Schull J, Kaplan H, O'Brien CP: Naloxone can alter experimental pain and mood in humans. Physiol Psychol 9:245-251, 1981
49. Stacher G, Abatzi TA, Schulte F, et al: Naloxone does not alter the perception of pain induced by electrical and thermal stimulation of the skin in healthy humans. Pain 34:271-276, 1988
50. Lautenbacher S, Roscher S, Strian D, et al: Pain perception in depression: Relationships to symptomatology and naloxone-sensitive mechanisms. Psychosom Med 56:345-352, 1994
51. Facchinetti F, Martignoni E, Sola D, et al: Transient failure of central opioid tonus and premenstrual symptoms. J Reprod Med 33:633-638, 1988
52. Marbach JJ, Lennon MC, Dohrenwend BP: Candidate risk factors for temporomandibular pain and dysfunction syndrome: Psychosocial, health behavior, physical illness and injury. Pain 34:139-151, 1988
53. Maixner W, Fillingim R, Booker D, et al: Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 63:341-351, 1995
54. Fillingim RB, Maixner W: Gender differences in the responses to noxious stimuli. Pain Forum 4:209-221, 1995